CYP2D6 is a key drug-metabolizing enzyme responsible for breaking down 20–25% of common medications, including beta-blockers, antidepressants, opioids, and antipsychotics. Your genotype (e.g., poor, intermediate, extensive, or ultrarapid metabolizer) primarily predicts how quickly you process these drugs. Direct lifestyle implications – such as diet, exercise, or stress resilience – are not supported by robust evidence. Some consumer tests market CYP2D6 as a 'detox gene' or link it to personality traits like anxiety, but the data are weak and inconsistent. Even if your test includes CYP2D6, you should not make lifestyle changes based solely on this result. The main clinical value lies in pharmacogenetics: it can guide medication choice and dosing when prescribed by a doctor. Without that context, the genotype has limited practical meaning for daily life. MyBody-X does not appear to offer a dedicated CYP2D6 test; if it does, the evidence for lifestyle applications remains insufficient.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-a06f66f846e9ffc7fdefcba9